ESR1 and breast cancer: Indeed, in a per se non-immunogenic environment, such as the breast, the presence of stromal and/or intratumoral TILs seems to fully support that breast cancer (BC) is immunogenic, especially concerning estrogen receptor (ER) negative disease [3, 4].